Evidence map›Paper›PMID 32030073›Full record

ArticleJournal of family & community medicine

Association between type 2 diabetes mellitus and

Abdullah M Alzahrani, Areej A Al Zaidi, Shahad M Alzahrani, Sultana A Binmahfouz, Fayssal M Farahat

Abstract read
In one paragraph

Article in Journal of family & community medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Immunokinetic signatures ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Metabolism open · 2025
    Review
  3. Article
  4. Review
  5. Eradication Rate and Factors InfluencingInternational journal of general medicine · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdullah M AlzahraniDepartment of Family Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, King Abdulaziz Medical City, Jeddah, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Areej A Al ZaidiDepartment of Family Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Shahad M AlzahraniDepartment of Family Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Sultana A BinmahfouzDepartment of Family Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Fayssal M FarahatDepartment of Family Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, King Abdulaziz Medical City, Jeddah, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReports on MATERIALS AND

methodsFollowing a cross-sectional design, participants were recruited from four National Guard Primary Health Care Centers in Jeddah City, Saudi Arabia. The study was conducted from December 2017 to November 2018. All participants underwent hemoglobin A1C (HbA1c) assessment and stool antigen test for

resultsA total of 212 type 2 diabetic patients aged 40 years or more, and 209 age-matched nondiabetic subjects were included in the study. About one-quarter of the diabetics and nondiabetics were positive for

conclusionAbout one-quarter of type 2 diabetics and nondiabetics in Jeddah City have

Indexed as

Diabetes mellitus type 2Helicobacter pyloririsk factorsstool antigen test

Identifiers

PMID32030073
PMCPMC6984031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.